%{search_type} search results

• Growth and development
• The orthopaedic history
• The orthopaedic examination : a comprehensive overview
• The orthopaedic examination : clinical application
• Gait analysis
• The limping child
• Back pain
• Disorders of the neck
• Scoliosis
• Kyphosis
• Other anatomic disorders of the spine
• Disorders of the upper extremity
• Developmental dysplasia of the hip
• Legg-calvé-perthes disease
• Slipped capital femoral epiphysis
• Congenital coxa vara
• Disorders of the femur
• Disorders of the leg
• Disorders of the foot
• Limb length discrepancy
• Limb deficiencies
• Arthritis
• Infections of the musculoskeletal system
• General principles of tumor management
• Benign musculoskeletal tumors
• Malignant bone tumors
• General principles of managing orthopaedic injuries
• Spinal injuries
• Upper extremity injuries
• Lower extremity injuries
• Disorders of the brain
• Disorders of the spinal cord
• Poliomyelitis
• Disorders of the peripheral nervous system
• Muscle diseases
• Skeletal dysplasias
• Orthopaedic-related syndromes
• Metabolic and endocrine disorders of bone
• Hematologic disorders
• Pediatric sports medicine : issues in contemporary sports participation.

""Ce jour-là j'ai compris ce qui me troublait. Peut-être moins le spectacle de la douleur, de la déraison, du dénuement, que cette lutte qui ne s'éteint jamais, au bout d'un an comme de vingt, en dépit des traitements qui érodent la volonté et du sens de la défaite, ça ne meurt jamais, c'est la vie qui insiste, dont on ne vient jamais à bout malgré la chambre d'isolement et les injections à haute dose. Tous refusent, contestent, récusent, aucune folie ne les éloigne définitivement de cet élan-là. " Durant toute une année, Joy Sorman s'est rendue au pavillon 4B d'un hôpital psychiatrique et y a recueilli les paroles de ceux que l'on dit fous et de leurs soignants. De ces hommes et de ces femmes aux existences abîmées, l'auteure a fait un livre dont Franck, Maria, Catherine, Youcef, Barnabé et Robert sont les inoubliables personnages. À la folie est le roman de leur vie enfermée."--Page 4 of cover.

• Section I. Developmental, psychological and social aspects of aging
• Chapter 1. Life course-developmental and transitional events
• Chapter 2. Demography and epidemiology
• Chapter 3. Culture and gender
• Chapter 4. Family and community
• Chapter 5. Ethics and forensics
• Chapter 6. Economics and health policy
• Section II. Biological aspects of aging
• Chapter 7. Neuroanatomy and neuropathology
• Chapter 8. Biochemistry and neuropharmacology
• Chapter 9. Anatomy and physiology
• Section III. Psychiatric diagnosis
• Chapter 10. Neurocognitive disorders
• Chapter 11. Depressive disorders and bipolar and related disorders
• Chapter 12. Sleep-wake disorders
• Chapter 13. Schizophrenia spectrum and other psychotic disorders
• Chapter 14. Substance-related and addictive disorders
• Chapter 15. Anxiety disorders and obsessive- compulsive and related disorders
• Chapter 16. Sexual dysfunctions, Gender dysphoria/ Paraphilic disorders
• Section IV. Diagnostic methods
• Chapter 17. Interviewing and history taking
• Chapter 18. Mental status examination, including quantitative cognitive screening
• Chapter 19. Functional assessment
• Chapter 20. Psychological and neuropsychological testing
• Chapter 21. Neurologic examination
• Chapter 22. Clinical laboratory testing
• Chapter 23. Structural and functional imaging
• Section V. Treatments
• Chapter 24. Pharmacokinetics and pharmacodynamics
• Chapter 25. Cytochrome (CYP)-450
• Chapter 26. Antidepressants
• Chapter 27. Mood stabilizers
• Chapter 28. Antipsychotics
• Chapter 29. Anxiolytics
• Chapter 30. Hypnotics
• Chapter 31. Cognitive enhancers
• Chapter 32. Stimulants
• Chapter 33. Drugs for Tardive Dyskinesia
• Chapter 34. Adverse effects of drugs
• Chapter 35. Interventional Psychiatry
• Chapter 36. Psychotherapy
• Chapter 37. Interdisciplinary approaches
• Chapter 38. Setting-specific treatment issues
• Chapter 39. Special management problems
• Section VI. Policy, ethical and legal issues
• Chapter 40. Role of geriatric psychiatrist in health care systems
• Chapter 41. Medico-legal
• Chapter 42. Ethics
• Chapter 43. Treatment-setting regulations
• Section VII. Medical and neurologic aspects of geriatric psychiatry Raj and Deena
• Chapter 44. Geriatric medical syndromes
• Chapter 45. Care of patients with neurologic disease
• Chapter 46. Psychiatric disorders due to a general medical condition
• Chapter 47. Psychiatric complications of medical treatment
• Chapter 48. Psychological factors affecting medical conditions.
• (source: Nielsen Book Data)

This book provides a comprehensive yet concise review of geriatric psychiatry in preparation for the board exam, or for reference during practice. Written by experts in the field, this text thoroughly reviews over 500 developmental, biological, diagnostic, and treatment questions for board certification. Unlike any other text on the market, this book takes a broader approach to the subject, making it accessible for physicians as well as other clinicians, including nurses, therapists, and social workers. Absolute Geriatric Psychiatry Review is an excellent resource for all clinicians who will care for the mental health of aging patients, including psychiatrists, neurologists, psychologists, therapists, nurses, social workers, nursing home administrators, and all others.
(source: Nielsen Book Data)

• Part One. Acupuncture for Brain, Introduction and Theory .-
• 1. Brain in original Traditional Chinese Medicine. -
• 2. Acupuncture and The Brain Current Understanding.-
• 3. Acupuncture Research and the Brain .-
• 4. Acupuncture Brain. physiology and Pathology.-
• 5. Scalp acupuncture.-
• 6. Dao qi acupuncture technique .-
• 7. Abdominal acupuncture .-
• 8. Other Commonly used acupuncture techniques for Brain conditions .-
• 9. Commonly used Herb formulas for Brain Conditions .-
• 10. The Chinese View-Preserving a Healthy Functioning Brain .-
• 11. Stroke .-
• 12. Parkinson's disease .-
• 13. Dementia and Alzheimer's disease.-
• 14. Multiple Sclerosis.-
• 15. Brain Injuries .-
• 16. Cerebral palsy and Brain retardation. .-
• 17. Other neurological conditions.-
• 18. Depression .-
• 19. Anxiety.-
• 20. Bipolar Disease .-
• 21. Autism .-
• 22. Other psychological conditions .-
• 23. Other brain related conditions .- Conclusion.- Appendix.- Index.
• (source: Nielsen Book Data)

This book systematically introduces the Brain in Traditional Chinese Medicine (TCM) and its acupuncture treatments. It discusses the origin and development of the TCM Brain theory, and presents current research on brain and acupuncture, the unique brain related techniques such as scalp acupuncture and Dao-qi technique, the new developing acupuncture treatment methods for brain-related conditions, such as stroke, Parkinson's, dementia, Alzheimer's disease, multiple sclerosis, traumatic brain injury, autism, cerebral palsy and depression, anxiety, bipolar disorder among others. This book is of interest to TCM and acupuncture practitioners in the West, as well as acupuncture researchers and lecturers. It gives a new understanding of the brain and treatments for brain-related conditions from a complementary medicine point of view.
(source: Nielsen Book Data)

• 1. Burden, cost, and epidemiology of acute rheumatic fever and rheumatic heart disease
• 2. Pathogenesis of acute rheumatic fever
• 3. Clinical evaluation and diagnosis of acute rheumatic fever
• 4. Management of acute rheumatic fever
• 5. Clinical evaluation and diagnosis of rheumatic heart disease
• 6. Medical management of rheumatic heart disease
• 7. Catheter-based investigation and treatment of rheumatic heart disease
• 8. Surgical management of rheumatic heart disease
• 9. Rheumatic heart disease in pregnancy
• 10. Primordial and primary prevention prevention of ARF and RHD
• 11. Secondary prevention of ARF and RHD
• 12. Control programmes, registries, and access to care
• 13. Rheumatic heart disease screening
• 14. Group A streptococcal vaccine
• 15. Advocacy and education
• 16. Acute complications and Emergencies of ARF and RHD.
• (source: Nielsen Book Data)

Acute Rheumatic Fever and Rheumatic Heart Disease is a concise, yet comprehensive, clinical resource highlighting must-know information on rheumatic heart disease and acute rheumatic fever from a global perspective. Covering the major issues dominating the field, this practical resource presents sufficient detail for a deep and thorough understanding of the latest treatment options, potential complications, and disease management strategies to improve patient outcomes. Divided into four distinct sections for ease of navigation: Acute Rheumatic Fever, Rheumatic Heart Disease, Population-Based Strategies for Disease Control, and Acute and Emergency Presentations. International editors and chapter authors ensure a truly global perspective. Covers all clinical aspects, including epidemiology, pathophysiology, clinical features, diagnosis, management, and treatment. Includes key topics on population-based measures for disease control for effective primary, secondary, and tertiary prevention. Consolidates today's available information and guidance into a single, convenient resource.
(source: Nielsen Book Data)

• Burden, cost, and epidemiology of acute rheumatic fever and rheumatic heart disease
• Pathogenesis of acute rheumatic fever
• Clinical evaluation and diagnosis of acute rheumatic fever
• Management of acute rheumatic fever
• Clinical evaluation and diagnosis of rheumatic heart disease
• Medical management of rheumatic heart disease
• Catheter-based investigation and treatment of rheumatic heart disease
• Surgical management of rheumatic heart disease
• Rheumatic heart disease in pregnancy
• Primordial and primary prevention prevention of ARF and RHD
• Secondary prevention of ARF and RHD
• Control programmes, registries, and access to care
• Rheumatic heart disease screening
• Group A streptococcal vaccine
• Advocacy and education
• Acute complications and Emergencies of ARF and RHD.

Acute Rheumatic Fever and Rheumatic Heart Disease is a concise, yet comprehensive, clinical resource highlighting must-know information on rheumatic heart disease and acute rheumatic fever from a global perspective. Covering the major issues dominating the field, this practical resource presents sufficient detail for a deep and thorough understanding of the latest treatment options, potential complications, and disease management strategies to improve patient outcomes. Divided into four distinct sections for ease of navigation: Acute Rheumatic Fever, Rheumatic Heart Disease, Population-Based Strategies for Disease Control, and Acute and Emergency Presentations. International editors and chapter authors ensure a truly global perspective. Covers all clinical aspects, including epidemiology, pathophysiology, clinical features, diagnosis, management, and treatment. Includes key topics on population-based measures for disease control for effective primary, secondary, and tertiary prevention. Consolidates today's available information and guidance into a single, convenient resource.

• The Incidence and Clinical Impact of Adenomyosis.- The Pathogenesis of Adenomyosis.- The Pathology of Adenomyosis.- The Clinical Features and Diagnosis of Adenomyosis.- Adenomyosis and Pain.- Adenomyosis and Abnormal Uterine Bleeding.- Adenomyosis and Infertility.- Ultrasound Manifestation and Classification of Adenomyosis.- MRI Manifestation and Classification of Adenomyosis.- The Medical Treatment of Adenomyosis.- The Surgical Treatment for Adenomyosis.- Uterine Artery Embolization Treatment for Adenomyosis.- Principles and Protocols of HIFU Ablation.- HIFU Ablation.- The Therapeutic Result of HIFU Ablation for Adenomyosis.- Adjuvant Therapy of HIFU Ablation for Adenomyosis.-Pregnancy Outcomes after Myomectomy and HIFU Treatment.- Conclusions.
• (source: Nielsen Book Data)

This book aims to provide updated facts and treatments for practicing gynecologists and postgraduate doctors to enhance their understanding of pathogenesis, pathology, symptoms and diagnostic imaging technology of adenomyosis, such as to select appropriate treatments, to improve the symptoms, fertility and the quality of life of women with adenomyosis. This book also particularly introduces the new treatment for adenomyosis using the non-invasive High Intensity Focused Ultrasound ablation treatment. Hopefully, it will provide a better understanding of its operation, effectiveness, and pregnancy outcome, to formulate a more successful treatment strategy for this disease.
(source: Nielsen Book Data)

• 1. Biomechanics and Rehabilitation Engineering.-
• 2. Biomaterials and Tissue Engineering.-
• 3. Biomedical Signal Processing.-
• 4. Medical Imaging and Clinical intervention.-
• 5. Biomedical Image Processing.-
• 6. Biomedical Instrumentation and Medical Devices.-
• 7. Telemedicine and Internet of Things.-
• 8. Medical Diagnostic and point-of care diagnostic and therapeutic devices.
• (source: Nielsen Book Data)

This book comprises select peer-reviewed papers presented at the International Conference on Biomedical Engineering Science and Technology: Roadway from Laboratory to Market (ICBEST 2018) organized by Department of Biomedical Engineering, National Institute of Technology Raipur, Chhattisgarh, India. The book covers latest research in a wide range of biomedical technologies ranging from biomechanics, biomaterials, biomedical instrumentation to tele-medicine, internet of things, bioinformatics, medical signal and image processing. The contents aim to bridge the gap between laboratory research and feasible market products by identifying potential technologies to enhance functionalities of diagnostic and therapeutic devices. The book will be of use to researchers, biomedical engineers, as well as medical practitioners.
(source: Nielsen Book Data)

• INTRODUCTION
• CHAPTER 1 - Cancer: concepts and epidemiology
• 1.1 A brief history of cancer
• 1.2 What is Cancer?
• 1.3 Cancer Epidemiology
• CHAPTER 2 - Cancer development and immunology
• 2.1 Cell cycle
• 2.1.1 Cell cycle control: the function of cyclins
• 2.2 Cancer triggering agents
• 2.2.1 Proto-oncogenes
• 2.2.2 Tumor suppressor genes
• 2.3 Development of tumor mass
• 2.4 Cancer Immunology
• CHAPTER 3 - Discovery of tumor markers
• 3.1 Cancer diagnosis
• 3.2 Impact of the discovery of tumor markers
• 3.2.1 Main tumor markers for cancer diagnosis
• 3.2.1.1 Alpha-fetoprotein (AFP)
• 3.2.1.2 Human Chorionic Gonadotropin ( -HCG)
• 3.2.1.3 Mucin-like cancer-associated antigen (MCA)
• 3.2.1.4 CA 15.3
• 3.2.1.5 Carcinoembryonic antigen (CEA)
• 3.2.1.6 Bladder tumor antigen (BTA)
• 3.2.1.7 Telomerase
• 3.2.1.8 Nuclear matrix protein (NMP 22)
• 3.2.1.9 Cyfra 21.1
• 3.2.1.10 Prostatic acid phosphatase (PAP)
• 3.2.1.11 Prostate-specific antigen (PSA)
• 3.2.1.12 CA 125
• 3.2.1.13 CA 19.9
• 3.2.1.14 p53
• 3.2.1.15 CA 72.4
• 3.2.1.16 K-ras
• 3.2.1.17 HER2
• 3.3 Cancer staging
• CHAPTER 4 - Conventional cancer treatment
• 4.1 Therapeutic modalities of cancer
• 4.2 Surgery
• 4.3 Radiotherapy
• 4.4 Antineoplastic chemotherapy
• 4.4.1 Classification of antineoplastic agents by cycle
• 4.4.1.1 Specific cycle antineoplastics
• 4.4.1.2 Nonspecific antineoplastic agents
• 4.4.2 Classification of antineoplastic agents by chemical structure and function
• 4.4.2.1 Alkylating agents
• 4.4.2.2 Antimetabolites
• 4.4.2.3 Plant-derived antineoplastics
• 4.4.2.4 Antitumor antibiotics
• 4.4.3 Chemotherapy toxicity
• 4.4.3.1 Hematological toxicity
• 4.4.3.2 Liver toxicity
• 4.4.3.3 Cardiac toxicity
• 4.4.3.3.1 Anthracyclines
• 4.4.3.3.2 Fluoropyrimidine
• 4.4.3.3.3 Taxanes
• 4.4.3.4 Pulmonary toxicity
• 4.4.3.5 Neurological toxicity
• 4.4.3.6 Renal toxicity
• 4.4.3.7 Gastrointestinal toxicity
• 4.4.3.8 Metabolic changes
• CHAPTER 5 - Targeted therapies in cancer treatment
• 5.1 Overexpressed receptors on tumor cells
• 5.2 Immunotherapy
• 5.3 Monoclonal antibodies
• 5.3.1 Types of monoclonal antibodies
• 5.3.2 Side effects of monoclonal antibodies
• 5.4 Checkpoint Inhibitors
• 5.4.1 Side effects of checkpoint inhibitors
• 5.5 Cancer Vaccines
• 5.5.1 Vaccines in cancer prevention
• 5.5.2 Vaccines for the treatment of cancer
• 5.6 Non-specific immunotherapies
• 5.7 Tyrosine kinase inhibitors
• 5.7.1 Imatinib
• 5.7.2 Gefitinib
• 5.7.3 Erlotinib
• 5.7.4 Sorafenib
• 5.7.5 Dasatinib
• 5.7.6 Nilotinib
• 5.7.7 Lapatinib
• 5.7.8 Adverse events of tyrosine kinase inhibitors
• CHAPTER 6 - Conventional chemotherapy vs. targeted therapy
• 6.1 Differences between conventional chemotherapy and targeted therapy
• 6.2 Risks and benefits of conventional chemotherapy compared to targeted therapy
• 6.3 Eligibility criteria for the indication of the targeted therapy
• 6.3.1 Side effects of targeted therapy
• 6.4 Can targeted therapy replace conventional chemotherapy?
• 6.4.1 Targeted therapy associated with conventional chemotherapy
• CHAPTER 7 - Pharmaceutical nanotechnology applied to cancer
• 7.1 Pharmaceutical nanotechnology
• 7.2 Classification of nanosystems
• 7.2.1 Liposomes
• 7.2.2 Micelles
• 7.2.3 Polymeric nanoparticles
• 7.2.4 Solid lipid nanoparticles
• 7.2.5 Magnetic nanoparticles
• 7.2.6 Metal nanoparticles
• 7.3 Main functions of nanosystems in cancer
• 7.3.1 Pharmaceutical nanotechnology in cancer diagnosis
• 7.3.2 Pharmaceutical nanotechnology for cancer treatment.
• (source: Nielsen Book Data)

This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment. We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells. The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment. This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology.
(source: Nielsen Book Data)

• SECTION I: Point of Care Ultrasound: Introduction and advantages of point of care ultrasound in intensive care.- Modes and equipment.- Sonography of the kidneys.- Ultrasound guidance for procedure.- Lung ultrasound and cardiac assessment for intravascular volume status.- Permanent vascular access for hemodialysis.- Focused echocardiogram.- Need for training and certification.-
• SECTION II: Diagnostics: Fluid overload and kidney injury score: a multidimensional real-time assessment of renal disease burden in the critically ill patient.- Blood volume monitoring on fluid removal during intermittent hemodialysis of critically ill children with acute kidney injury.- Subclinical acute kidney injury and adverse outcomes in critically ill neonates and children.- Acute kidney injury defined by fluid corrected creatinine in neonates after the cardiac surgeries.- Pediatric AKI based on the reference change value of serum creatinin-pROCK.- Cardiac surgery-associated kidney injury in children and renal oximetry.- Serum and urine FGF23 and IGFBP-7 for the prediction of acute kidney injury in critically ill children.- Renal functional reserve and furosemide stress test.- Associations of perioperative renal oximetry via near-infrared spectroscopy, and postoperative acute kidney injury in infants after congenital heart surgery.- Using age-specific biomarker ranges for diagnosis and prognosis in pediatric AKI.
• (source: Nielsen Book Data)

The book covers advances in critical care pediatric nephrology, including care of sick children with acute kidney injury. The book contains detailed guidance on point of care ultrasound in children with acute kidney injury and use of biomarkers in critically sick children. This is an annual theme-based book with the current theme of 'point of care ultrasound in critical care pediatric nephrology and newer diagnostics in acute kidney injury'. This is the first book of the set of books to be published annually with a different theme related to critical care pediatric nephrology each year with the collaboration of the Pediatric Continous Renal Replacement Therapy (PCRRT) Foundation and International Collaboration of Nephrologists & Intensivists for Critical Care in Children (ICONIC). This annual updates book contains 20 chapters, written and edited by leading experts in pediatric intensive care, pediatric nephrology and nephrologists specializing in point of care ultrasound from across the globe. It includes top studies in the last few years in critical care pediatric nephrology on point of care ultrasound and diagnostics. Chapters cover scientifically updated information by international experts on each topic. It offers assistance to pediatricians, pediatric nephrologists, pediatric intensivists and residents.
(source: Nielsen Book Data)

• Section 1: Introduction
• Chapter 1:
• Introduction: An overview of host-directed therapies for tuberculosis
• Daniel Frank, Robert Mahon
• Section 2: Targeting immunometabolism
• Chapter 2:
• Sirtuin deacetylases: Linking Mycobacterial infection and host metabolism
• Lorissa Smulan, Hardy Kornfeld, and Amit Singhal
• Chapter 3:
• The mammalian target of rapamycin complex 1 (mTORC1): an ally of M. tuberculosis in host cells
• Natalie Bruiners, Valentina Guerrini, Maria Laura Gennaro
• Chapter 4:
• HIF-1 as a potential therapeutic target for tuberculosis treatment
• Qingkui Jiang, Maria Laura Gennaro, Lanbo Shi
• Chapter 5:
• Nuclear receptors in host-directed therapies against tuberculosis
• Eun-Kyeong Jo
• Section 3: Enhancing anti-mycobacterial mechanisms
• Chapter 6:
• Autophagy as a target for host-directed therapy against tuberculosis
• Surbhi Verma, Raman Deep Sharma and Dhiraj Kumar
• Chapter 7:
• Metformin: a leading HDT candidate for TB
• Amit Singhal and Hardy Kornfeld
• Chapter 8:
• Statins as host-directed therapy for tuberculosis
• Noton K. Dutta, Petros C. Karakousis
• Chapter 9:
• Antimycobacterial attributes of mitochondria: An insight into host defense mechanisms
• Rikesh K Dubey, Apoorva Narain
• Section 4: Targeting immune cells
• Chapter 10:
• Conventional and unconventional lymphocytes in immunity against Mycobacterium tuberculosis
• Paula Ruibal, Tom H.M. Ottenhoff, Simone A. Joosten
• Chapter 11:
• Targeting inhibitory cells such as Tregs and MDSCs in the tuberculous granuloma
• Sadiya Parveen, John R. Murphy, and William R. Bishai
• Chapter 12:
• Targeting suppressor T cells
• Leanie Kleynhans, Gerhard Walzl
• Chapter 13:
• Neutrophil-mediated mechanisms as targets for host-directed therapies against tuberculosis
• Tobias Dallenga, Ulrich E. Schaible
• Chapter 14:
• Type I interferon and interleukin-1 driven inflammatory pathways as targets for HDT in tuberculosis
• Katrin D. Mayer-Barber, Christopher M. Sassetti
• Chapter 15:
• Mucosal-associated invariant and V 9V 2 T cells
• Charles K. Vorkas, Michael S. Glickman
• Chapter 16:
• Airway epithelial cells
• Angelica M. Olmo-Fontanez, Jordi B. Torrelles
• Section 5: Preclinical models for assessing HDTs
• Chapter 17:
• In vitro models of human granuloma formation to analyze host-directed therapies
• Liku B. Tezera, Michaela T. Reichmann, Basim Al Shammari, Paul T. Elkington
• Chapter 18:
• C3HeB/FeJ as a key mouse strain for testing host-directed therapies against tuberculosis
• Pere-Joan Cardona, Cristina Vilaplana
• Chapter 19:
• The Rabbit Model for Assessing Host-Directed Therapies for Tuberculosis
• Selvakumar Subbian, Gilla Kaplan
• Section 6: Clinical trials of HDTs and special considerations for study endpoints
• Chapter 20:
• Clinical trials of TB-HDT candidates
• Robert S. Wallis
• Chapter 21:
• Outcomes for clinical trials of host-directed therapies for tuberculosis
• Akshay N. Gupte, Sara C. Auld, William N. Checkley, Gregory P. Bisson
• Chapter 22:
• Pharmacological considerations for clinical trials of host-directed therapies for tuberculosis
• Elisa H. Ignatius, Kelly E. Dooley.
• (source: Nielsen Book Data)

• Section 1: Introduction
• Chapter 1: Introduction: An overview of host-directed therapies for tuberculosis
• Section 2: Targeting immunometabolism
• Chapter 2: Sirtuin deacetylases: Linking Mycobacterial infection and host metabolism
• Chapter 3:The mammalian target of rapamycin complex 1 (mTORC1): an ally of M. tuberculosis in host cells
• Chapter 4: HIF-1α as a potential therapeutic target for tuberculosis treatment
• Chapter 5: Nuclear receptors in host-directed therapies against tuberculosis
• Section 3: Enhancing anti-mycobacterial mechanisms
• Chapter 6: Autophagy as a target for host-directed therapy against tuberculosis
• Chapter 7: Metformin: a leading HDT candidate for TB
• Chapter 8: Statins as host-directed therapy for tuberculosis
• Chapter 9: Antimycobacterial attributes of mitochondria: An insight into host defense mechanisms
• Section 4: Targeting immune cells
• Chapter 10: Conventional and unconventional lymphocytes in immunity against Mycobacterium tuberculosis
• Chapter 11: Targeting inhibitory cells such as Tregs and MDSCs in the tuberculous granuloma
• Chapter 12: Targeting suppressor T cells
• Chapter 13: Neutrophil-mediated mechanisms as targets for host-directed therapies against tuberculosis
• Chapter 14: Type I interferon and interleukin-1 driven inflammatory pathways as targets for HDT in tuberculosis
• Chapter 15: Mucosal-associated invariant and Vγ9Vδ2 T cells
• Chapter 16: Airway epithelial cells.-Section 5: Preclinical models for assessing HDTs
• Chapter 17: In vitro models of human granuloma formation to analyze host-directed therapies
• Chapter 18: C3HeB/FeJ as a key mouse strain for testing host-directed therapies against tuberculosis
• Chapter 19: The Rabbit Model for Assessing Host-Directed Therapies for Tuberculosis
• Section 6: Clinical trials of HDTs and special considerations for study endpoints
• Chapter 20:Clinical trials of TB-HDT candidates
• Chapter 21:Outcomes for clinical trials of host-directed therapies for tuberculosis
• Chapter 22: Pharmacological considerations for clinical trials of host-directed therapies for tuberculosis.

This book discusses specific immune cell regulatory pathway(s), immune cell types, or other mechanisms involved in host responses to tuberculosis that can be potentially targeted for host-directed therapy (HDT). The pathways/mechanisms investigated are either protective - thus calling for pathway/factor enhancing drugs - or maladaptive - thus calling for pathway/factor inhibitory drugs. Discovery and development (pre-clinical and clinical) of candidate HDT agents will also be elucidated, as well as approaches for HDT of other diseases. The benefit to the reader will derive from learning about the biology of multiple host pathways involved in health and disease, how these pathways are disrupted or dysregulated during tuberculosis, and which druggable targets exist in these pathways. This book provides the reader with a roadmap of current and future directions of HDT against tuberculosis. Since the host pathways/factors involved in protective or maladaptive responses to tuberculosis are not disease-specific, information learned from the context of tuberculosis likely will be relevant to other infectious and non-infectious diseases.
(source: Nielsen Book Data)

• Fundamentals of polymeric nanomaterials Synthesis of polymer nanomaterials, mechanisms, and their structural control Polymeric nanomaterials in drug delivery Nanostructures in gene delivery Dendrimer-based nanoformulations as drug carriers for cancer treatment Polymer nanomaterials in bioimaging Polymeric nanoparticles used in tissue engineering Polymeric nanomaterials as broad-spectrum antimicrobial compounds Polymeric nanomaterials for targeting the cellular suborganelles Polymeric nanomaterials in neuroscience Polymeric nanomaterials for ocular drug delivery Current and future challenges in polymeric nanomaterials for biomedical applications.
• (source: Nielsen Book Data)

Advances in Polymeric Nanomaterials for Biomedical Applications examines advanced polymer synthetic strategies for developing novel biomaterials for use in medicine. With a strong focus on fundamentals and structure, the authors also explore their fabrication, along with their current and potential biomedical applications. The book begins with a look at the fundamentals of polymeric nanomaterials and their properties and then discusses the design of biomaterials and their applications in drug delivery. Further chapters explore important applications, such as imaging and regenerative medicine, including current challenges and future trends. This valuable resource is especially useful for materials and polymer scientists, and bioengineers wishing to broaden their knowledge of polymeric nanobiomaterials.
(source: Nielsen Book Data)

• Intro
• Preface
• Contents
• About the Editors
• Chapter 1: Probiotics and Their Potential Applications: An Introduction
• 1.1 Introduction
• 1.2 Classification: Probiotics, Prebiotics, Synbiotics and Postbiotics
• 1.2.1 Probiotic
• 1.2.1.1 Lactobacillus Species
• 1.2.1.2 Bifidobacterium Species
• 1.2.1.3 Bacillus Species
• 1.2.1.4 Saccharomyces Species
• 1.2.2 Prebiotic
• 1.2.2.1 Types of Prebiotics
• 1.2.2.2 Mechanisms of Action of Prebiotics
• 1.2.3 Synbiotic
• 1.2.4 Postbiotics
• 1.3 Colonization and Alterations of Gut Microflora

• 1.4 Immune System and Gastrointestinal Response to Probiotics
• 1.5 Potential Applications of Probiotics
• 1.5.1 Antimicrobial Activities of Probiotics
• 1.5.2 Anti-inflammatory Intestinal Activity of Probiotics
• 1.5.3 Anti-cancer Activity of Probiotics
• 1.5.4 Anti-allergic Activities of Probiotics
• 1.5.5 Anti-obesity Activity of Probiotics
• 1.5.6 Effect of Probiotics on Brain and Central Nervous System
• 1.6 Commercial Potential of Probiotics
• 1.6.1 Dairy Based Probiotic Products
• 1.6.2 Non-dairy Based Probiotic Products
• 1.6.2.1 Fruit Based Probiotic Products

• 1.6.2.2 Vegetable Based Probiotic Products
• 1.6.2.3 Cereal Based Probiotic Product
• 1.6.2.4 Soy Based Probiotic Products
• 1.6.2.5 Meat Based Probiotic Products
• 1.6.2.6 Herbal Probiotic Formulations
• 1.6.3 Pharmaceutical Probiotic Formations
• 1.7 Conclusions
• References
• Chapter 2: Sources and Selection Criteria of Probiotics
• 2.1 Introduction
• 2.2 Sources of Probiotics
• 2.3 Selection Criteria for the Probiotics
• 2.4 Conclusion
• References
• Chapter 3: Indigenous Fermented Foods as a Potential Source of Probiotic Foods
• 3.1 Introduction

• 3.2 Food Fermentation: Socio-Economic Importance
• 3.3 Probiotics: Concept and Health-Improving Properties
• 3.4 Probiotics: Global Perspective on the Usages
• 3.5 Probiotic: Application in Fermented Foods
• 3.6 Fermented Foods and Beverages
• 3.7 Fermented Foods: Nutritional and Health Benefits
• 3.7.1 Fermented Milk Products
• 3.7.2 Fermented Soy/Cereal Products
• 3.7.3 Fermented Fruits and Vegetables
• 3.7.4 Bio-Preservation
• 3.7.5 Shelf Life of Probiotics
• 3.8 Conclusions and Future Prospects
• References
• Chapter 4: Prebiotics for Probiotics
• 4.1 Introduction

• 4.2 Prebiotics (PreBs)
• 4.3 How PreBs Qualify as Functional Foods?
• 4.4 Types and Sources of PreBs
• 4.4.1 Lactulose
• 4.4.2 Lactosucrose
• 4.4.3 Inulin and Fructo-Oligosaccharide (FOS)
• 4.4.4 Galacto-Oligosaccharide (GOS)
• 4.4.5 Soybean-Oligosaccharide (SOS)
• 4.4.6 Xylo-Oligosaccharide (XOS)
• 4.4.7 Isomalto-Oligosaccharide (IOS)
• 4.4.8 Resistant Starch
• 4.5 Therapeutic Effects of PreBs
• 4.5.1 Enhancing the Gut Health
• 4.5.2 Immunological Effects
• 4.5.3 Reducing the Risk of Colon Cancer
• 4.5.4 Bioavailability and Mineral Absorption

This book focuses on probiotics as sustainable foods and medicines, discussing issues such as screening and identification of probiotics, health claims, and advances in processing technologies, as well as food safety. Based on sound scientific research, the book is a unique reference resource for food scientists interested in development of probiotic based functional foods and their marketing. It will also appeal to those working in the area of regulations regarding the use of and health claims for fermented foods, both locally and globally.
(source: Nielsen Book Data)

• Introduction to and History of Psoriasis and Psoriasis Therapy.- Pathophysiology of Psoriasis/Novel Pathways.- Psoriasis: Clinical Review and Update.- Psoriasis: Epidemiology, Potential Triggers, Disease Course.- Topical Therapy I: Corticosteroids and Vitamin D Analogues.- Topical Therapy II: Retinoids, Immunomodulators, and Others.- Topical Therapy II: Retinoids, Immunomuodulators, and Others/ Ultraviolet Therapy for Psoriasis.- Laser Therapy for Psoriasis.- Traditional Systemic Therapy I: Methotrexate and Cyclosporine.- Traditional Systemic Therapy II: Retinoids and Others.- Apremilast.- Etanercept.- Adalimumab.- Infliximab, Golimumab , and Certolizumab Pegol.- Ustekinumab.- Guselkumab.- Tidrakizumab.- Risankizumab.- Secukinumab.- Ixekizumab.- Brodalumab.- Biosimilars for Psoriasis.- Research Pipeline I: Oral Therapeutics for Psoriasis.- Research Pipeline II: Upcoming Biologic Therapies.- Pediatric Psoriasis.- Challenges in Psoriasis Treatment: Nail, Scalp, and Palmoplantar Involvement.- Psoriasis and Comorbidities.- Summary of Published Treatment Guidelines.- Index.
• (source: Nielsen Book Data)

This extensively revised second edition provides an up-to-date and highly informative textbook on psoriasis. The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy. In addition, it provides a detailed overview of the pathophysiology, comorbidities, epidemiology and triggers of the disease. Advances in Psoriasis: A Multisystemic Guide extensively details the scientific basis and practice management of psoriasis. It is therefore a vital resource for practicing and trainee dermatologists looking to develop their clinical knowledge of how to manage and treat these patients.
(source: Nielsen Book Data)

The Arabic treatise edited and translated here was written in the middle of the 9th century CE by 'Ali ibn Sahl Rabban at-Tabari, a Christian convert to Islam and one of the most remarkable thinkers of his time. The text can be described as a manual towards the preservation of health, addressed directly to the 'Abbasid caliph al-Mutawakkil and his household. It represents not only the oldest extant specimen of its kind, but is also distinguished by its largely non-technical language, as well as by a narrative style that creates an unusual interface with classical Arabic prose literature. The Greek and Indian sources upon which at-Tabari relied testify to the synthetic and inclusive character of early Islamic medicine.
(source: Nielsen Book Data)

• 1. Memory, cognitive impairment & dementia.-
• 2. Dementia due to alzheimer's disease (ad).-
• 3. Dementia assessment.-
• 4. Rudas cognitive scale.-
• 5. Diagnosis.-
• 6. Supporting diagnosis & treatment.
• (source: Nielsen Book Data)

This book provides a practically focused resource on the methodologies available for diagnosing and treating Alzheimer's disease. The number of individuals affected by the disease continues to grow and as such there is an ever-increasing need for clear easy-to-digest guidance on how to appropriately diagnose and treat these patients. Within this work, chapters provide concise informative details of what this form of dementia is, how it can be diagnosed, managed and prevented making it ideal for those with limited experience in dealing with these patients. Information is provided on how to use a variety of the latest relevant techniques including mental state examinations, functional assessments, special investigations and the available drug treatments. Alzheimer's Disease: Diagnosis & Treatment Guide is a concise clinical guide detailing how to diagnose and treat these patients. It's easy-to-follow ideal for use by front-line physicians and trainees, who have no previous experience of diagnosing and treating this disease. The assessment component of the book is based on the WHO Mental Health Gap Action Plan (mhGAP) Dementia Intervention Guide for non-specialized settings.
(source: Nielsen Book Data)

• Part 1: Anatomy and Physiology of the Liver.-
• 1. Anatomy of HepatoPancreatoBiliary Surgery and Liver Transplantation Relevant to Anaesthesia.-
• 2. Anatomy and physiology of the liver.-
• Part 2: Liver transplantation.-
• 3. Pathophysiology behind cardiopulmonary complications of cirrhosis and portal hypertension.-
• 4. Liver Transplantation: Graft Variables.-
• 5. Surgical aspects of liver transplantation.-
• 6. PRE-ASSESSMENT FOR HEPATO-PANCREATO-BILIARY AND LIVER TRANSPLANT SURGERY.-
• 7. The Role of Cardiopulmonary Exercise Testing (CPET) in the Preoperative Assessment of Patients for Hepatico-Pancreatic-Biliary (HPB) Surgery and Liver Transplantation (LT).-
• 8. ANAESTHESIA for LIVER TRANSPLANTATION.-
• 9. How does the aetiology of primary liver disease affect anaesthesia for liver transplantation.-
• 10. Haemodynamic monitoring during liver transplant surgery.-
• 11. Point of care viscoelastic haemostasis monitoring during liver transplant surgery.-
• 12. HOW TO REDUCE BLEEDING AND BLOOD TRANSFUSION DURING LIVER TRANSPLANTATION.-
• 13. Fast tracking in liver transplant programme.-
• 14. Acute kidney injury in hepatico-pancreatic-biliary surgery and liver transplantation .-
• 15. Use of Extracorporeal Membrane Oxygenation during Liver Transplantation.-
• 16. Liver preservation with extracorporeal perfusion.-
• 17. Veno-venous bypass in liver transplantation.-
• Part 3: Liver resection.-
• 18. Biology of liver tumors and outcomes of liver surgery.-
• 19. Anaesthesia for Live Donor Hepatectomy.-
• 20. Strategies for low central venous pressure in liver resection surgery.-
• 21. ENHANCED RECOVER AFTER HPB SURGERY.-
• 22. Postoperative analgesia in liver resection surgery.-
• Part 4: Pancreas.-
• 23. Anatomy of liver resection surgery.-
• 24. Perioperative anaesthetic considerations for the Whipple procedure and other pancreatic surgeries.-
• 25. Anaesthetic management for patients undergoing pancreas transplantation.-
• Part 4: Paediatric.-
• 26. Anaesthesia for Paediatric Liver Surgery.-
• 27. Anaesthesia for Paediatric Liver Transplantation.-
• 28. Anaesthesia for Hepatico-Pancreatic-Biliary Surgery and Transplantation Communication between HPB anaesthetists: meetings, websites and forums.
• (source: Nielsen Book Data)

This concise, accessible book covers anesthesia for hepatico-pancreatic-biliary (HPB) surgery and transplantation, based on randomized clinical trials, meta-analyses, case series, reports, and hands-on experience. The anatomy, physiology, pathophysiology and clinical consequences are discussed, and the close ties between HPB resection and transplant anesthesia are explored. The content reflects current real-world practice, as liver and pancreatic transplant surgeries have substantially improved in terms of blood-loss reduction, fast tracking and reduced risk. The book also addresses anesthetic aspects in connection with the recently introduced and rapidly expanding practice of laparoscopic surgery; with enhanced recovery; and with pancreatic surgery. Anesthesia for Hepatico-Pancreatic-Biliary Surgery and Transplantation is intended for aspiring HPB and transplant anesthetists, anesthesia trainees, and consultants with experience in HPB anesthesia who want to see whether or not they're up to date on the current standards. .
(source: Nielsen Book Data)

• AIRWAY ANATOMY AND TRACHEOBRONCHIAL TREE
• OPTIMIZING INTUBATION POSITIONING
• HOW TO ASSEMBLE AND USE THE FIBEROPTIC SCOPE AND TOWER
• ASLEEP FIBEROPTIC INTUBATIONS
• AWAKE FIBEROPTIC INTUBATION
• Nasopharynx = Trigeminal nerve
• NASOTRACHEAL INTUBATION
• CODES / OUT OF OR EMERGENCY AIRWAY MANAGEMENT
• AIRWAY EXCHANGES
• DEEP EXTUBATIONS
• ASPIRATION ON INDUCTION
• INTUBATING WITHOUT MUSCLE RELAXANT
• JET VENTILATION FOR ENT SURGERY
• INTUBATING WITH BOUGIE
• INTUBATING WITH C-SPINE PRECAUTIONS
• INTUBATING WITH VIDEO LARYNGOSCOPE
• INTUBATING ON THE GROUND
• DOUBLE LUMEN ENDOTRACHEAL TUBES
• EMERGENCY CRICOTHYROIDOTOMY
• LARYNGEAL MASK AIRWAYS (LMAs)
• TROUBLESHOOTING TRACHEOSTOMIES
• ULTRASOUND-GUIDED PERIPHERAL IV'S
• WHERE TO LOOK FOR PIV'S
• SUBCLAVIAN CENTRAL LINES WITHOUT ULTRASOUND
• INTERNAL JUGULAR CENTRAL LINE WITHOUT ULTRASOUND
• FEMORAL LINES WITHOUT ULTRASOUND
• HOW TO ASSEMBLE AN ARTERIAL LINE TRANSDUCER
• RADIAL ARTERIAL LINES
• DORSAL PEDAL ARTERIAL LINES
• BELMONT INFUSER
• SINGLE SHOT SPINAL
• LUMBAR EPIDURALS
• CONTINUOUS SPINAL
• COMBINED SPINAL-EPIDURALS
• THORACIC EPIDURALS
• WET TAPS AND EPIDURAL BLOOD PATCHES
• TOTAL INTRAVENOUS ANESTHETICS (TIVA)
• MONITORED ANESTHESIA CARE/MAC
• EMERGENCE WITHOUT NITROUS OXIDE
• CRANIOTOMIES
• LIVER TRANSPLANTS
• PHASES OF LIVER TRANSPLANT
• ACKNOWLEDGEMENTS
• .
• (source: Nielsen Book Data)

This book describes in concise yet detailed step-by-step instructions on how to perform common procedures, including complex airway management, vascular access, neuraxial blocks, and nuanced anesthetic techniques; it not only covers this breadth of procedures, but presents them in an accessible manner. Chapters follow the format of the indications for a particular procedure, a list of equipment required, step-by-step instructions for performing the procedure, common complications, and troubleshooting techniques. The book is designed intentionally for the busy physician to be able to easily read the essential information, including lists of equipment necessary, numbered steps to perform the procedure, tables of common errors and methods to troubleshoot, indications and contraindications for procedures, detailed photos of equipment setup, and handmade diagrams and images. Anesthesiology Resident Manual of Procedures is comprehensive and written with the physician-in-training in mind, as well as those who are completing their residency or fellowship in the fields of anesthesiology, critical care medicine, and emergency medicine.
(source: Nielsen Book Data)

• 1. Applications of Mouse Models to the Study of Food Allergy
• Sara Benede and M. Cecilia Berin
• 2. Induction of Peanut Allergy through Inhalation of Peanut in Mice
• Joseph J. Dolence
• 3. Assessment of Immune Responses in an Animal Model of Wheat Food Allergy via Epicutaneous Sensitization
• Norimasa Tamehiro, Reiko Adachi, and Kazunari Kondo
• 4. A Mouse Model of Oral Sensitization to Hen's Egg White
• Sara Benede, Daniel Lozano-Ojalvo, Rosina Lopez-Fandino, and Elena Molina
• 5. Induction of Hypersensitivity with Purified Beta-Lactoglobulin as a Mouse Model of Cow's Milk Allergy
• Nicholas A. Smith and Kumi Nagamoto-Combs
• 6. Diet-induced Mouse Model of Atopic Dermatitis
• Masanori Fujii, Yuki Shimazaki, and Takeshi Nabe
• 7. Animal Models of Contact Dermatitis: 2,4-dinitrofluorobenzene-induced Contact Hypersensitivity
• Mario C. Manresa
• 8. Induction of Airway Hypersensitivity to Ovalbumin and Dust Mite Allergens as Mouse Models of Allergic Asthma
• Mei-Chi Chen, Jesse W Tai, and Cheng-Jang Wu
• 9. Generation and Characterization of Inducible Lung and Skin-Specific IL-22 Transgenic Mice
• Li Zhou, Tao Zheng, and Zhou Zhu
• 10. Experimental Mouse Models of Ragweed- and Papain-Induced Allergic Conjunctivitis
• Akira Matsuda, Toshiaki Hirakata, Yosuke Asada, and Susumu Nakae
• 11. Intravital Imaging of Vascular Permeability by Two-photon Microscopy
• Gyohei Egawa, Sachiko Ono, and Kenji Kabashima
• 12. Isotype-specific Detection of Serum Immunoglobulins against Allergens
• Danielle L. Germundson and Kumi Nagamoto-Combs
• 13. An Overview of Flow Cytometry: Its principles and applications in Allergic Disease Research
• Taylor Schmit, Mitchell Klomp, and M. Nadeem Khan
• 14. The Application of Flow Cytometry for Simultaneous and Multi-Parametric Analysis of Heterogenous Cell Populations in Basic and Clinical Research
• Taylor Schmit, Mitch Klomp, and M. Nadeem Khan
• 15. Cellular and Biochemical Analysis of Bronchoalveolar Lavage Fluid from Murine Lungs
• Rama Satyanarayana Raju Kalidhindi, Nilesh Sudhakar Ambhore, and Venkatachalem Sathish
• 16. Procedures to Evaluate Inflammatory and Pathological Changes during Allergic Airway Inflammation
• Savita P. Rao, Stephanie Rastle-Simpson, Mythili Dileepan, and P. Sriramarao
• 17. Assessment of Lung Eosinophils in situ using Immunohistological Staining
• Christopher D. Nazaroff, William E. LeSuer, Mia Y. Masuda, Grace Pyon, Paige Lacy, and Elizabeth A. Jacobsen
• 18. Preservation and Processing of Intestinal Tissue for the Assessment of Histopathology
• Juliane Rieger, Lisa-Marie Pelckmann, and Barbara Drewes
• 19. Antibiotic Treatment in an Animal Model of Inflammatory Lung Disease
• Alissa Cait, Melina Messing, Jessica Cait, Diana Canals Hernaez, and Kelly M. McNagny
• 20. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma
• Laura Hesse, Arjen H. Petersen, and Martijn C. Nawijn
• 21. T Cell Epitope Immunotherapy in Mouse Models of Food Allergy
• Christine Y.Y. Wai, Nicki Y.H. Leung, Ka Hou Chu, and Patrick S.C. Leung
• .
• (source: Nielsen Book Data)

This volume provides protocols for mouse models of allergic diseases and guidelines for choosing a particular strains, allergen, adjuvant, and route of sensitization. Chapters detail types of allergic disease, methods that are frequently employed to analyze pathophysiology of allergic diseases, manipulation of intestinal microbiota, and desensitization of immure responses in animal models. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Animal Models of Allergic Disease: Methods and Protocols aims to offer a comprehensive collection of protocols and experience-derived instructions to further allergic disease research.
(source: Nielsen Book Data)

• Series Preface... Preface... Foreword... Table of Contents... Contributing Authors...
• 1. Highly Processed Food and Binge Eating Ashley Gearhardt
• 2. The Binge Eating Prone/Binge Eating Resistant Animal Model: A Valuable Tool for Examining Neurobiological Underpinnings of Binge Eating Natasha Fowler, Nicollette Russell, Cheryl L. Sisk, Alexander W. Johnson, and Kelly L. Klump
• 3. Food Seeking in Spite of Harmful Consequences Rossella Ventura, Lucy Babicola, Diego Andolina, Enrico Patrono, and Matteo Di Segni
• 4. Assessment of Binge-Like Eating Behavior in Mice Utilizing a Weekly Intermittent Access Paradigm Tiffany Tang, Natalie Barker, James Krantz, Alysia Polito, Petr Telensky, Michael A. Statnick, and Traci Czyzyk
• 5. Predicting and Classifying Rats Prone to Overeating Fat Jessica R. Barson, Irene Morganstern, and Sarah F. Leibowitz
• 6. Psychosocial Stress and Diet History Promote Emotional Feeding in Female Rhesus Monkeys Vasiliki Michopoulos, Kelly Ethun, and Mark E. Wilson
• 7. Artificial Sweeteners in Animal Models of Binge Eating Gaelle Awad, Katia Befort, and Mary C. Olmstead
• 8. Intermittent, Extended Access Rodent Models of Compulsive Eating Eric P. Zorrilla, Alison D. Kreisler, and Samantha R. Spierling
• 9. Animal Models of Binge Eating: Hedonic Feeding and Alcohol Intake Julianna N. Brutman, Sunil Sirohi, and Jon F. Davis
• 10. Animal Models of Binge Eating Palatable Foods: Emergence of Addiction-Like Behaviors and Brain Changes in the Rat Miriam E. Bocarsly and Nicole M. Avena
• 11. Clinical and Preclinical Bariatric Surgery Approaches to Studying Obesity Panayotis K. Thanos, Abdulraouf Lamoshi, Amanda Nubelo, John Hamilton, Artur Chernoguz, Aaron B. Hoffman, Teresa Quattrin, and Carroll Harmon
• 12. Preference for Palatable Food, Impulsivity, and Relation to Drug Addiction in Rats Marilyn E. Carroll, Natalie E. Zlebnick, and Nathan A. Holtz
• 13. Impact of a History of Caloric Restriction and a Frustration Stress Manipulation on Binge-Like Eating Behavior in Female Rats: Preclinical Results Maria Vittoria Micioni Di Bonaventura, Emanuela Micioni Di Bonaventura, Luca Botticelli, and Carlo Cifani
• 14. Anorexia and Undereating Guido K.W. Frank
• 15. Activity-Based Anorexia, An Animal Model of Anorexia Nervosa for Investigating Brain Plasticity Underlying the Gain of Resilience Chiye Aoki
• 16. The Anorectic Phenotype of the anx/anx Mouse is Associated with Hypothalamic Dysfunction Ida A.K. Nilsson, Tomas Hoekfelt, and Martin Schalling
• 17. Exploring the Neural Underpinnings of an Antidepressant and Rewarding Action of Early Anorexia Valerie Compan
• 18. Food-Anticipatory Activity: Rat Models and Underlying Mechanisms Roger A.H. Adan
• 19. In Search for Perfection: An Activity-Based Rodent Model of Anorexia Magdalena Kurnik-Lucka, Kamil Skowron, and Krzysztof Gil Subject Index List...
• (source: Nielsen Book Data)

This second edition volume expands on the previous edition with discussions on the latest techniques and animal models used to study eating disorders, and the characterizations of behaviors and neurochemical alterations associated with them. Chapters in this book cover different contributing factors of eating disorders and explore topics such as highlight processed food and binge eating; predicting and classifying rates prone to overeating fat; artificial sweeteners in animal models of binge eating; clinical and preclinical bariatric surgery approaches to studying obesity; anorexia and undereating; and food-anticipatory activity in rat models and its underlying mechanisms. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and practical, Animal Models of Eating Disorders, Second Edition is a valuable resource for any researchers interested in learning more about this important and developing field. .
(source: Nielsen Book Data)